Open access
173
Views
53
CrossRef citations to date
0
Altmetric
Original Research
Reasons for discontinuation of subcutaneous biologic therapy in the treatment of rheumatoid arthritis: a patient perspective
Susan C Bolge1 Health Economics and Outcomes Research, Janssen Scientific Affairs, LLC, Horsham, PA, USACorrespondence[email protected]
, Amir Goren2 Health Outcomes Practice, Kantar Health, New York, NY, USA
& Neeta Tandon1 Health Economics and Outcomes Research, Janssen Scientific Affairs, LLC, Horsham, PA, USA
Pages 121-131
|
Published online: 20 Jan 2015
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.